NCT01219400View on ClinicalTrials.gov

Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes
Interventions
DRUG

Vildagliptin

Vildagliptin (50 mg BID) given for four weeks

Trial Locations (1)

22184

Lund University, Lund

All Listed Sponsors
lead

Lund University

OTHER

NCT01219400 - Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter